Proactiveinvestors United Kingdom SalvaRx https://www.tech-capital.com Proactiveinvestors United Kingdom SalvaRx RSS feed en Thu, 21 Nov 2019 20:53:03 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) SalvaRx doubles as it sells immuno-oncology assets to Portage for US$76mln https://www.tech-capital.com/companies/news/202841/salvarx-doubles-as-it-sells-immuno-oncology-assets-to-portage-for-us76mln-202841.html Tue, 14 Aug 2018 08:49:00 +0100 https://www.tech-capital.com/companies/news/202841/salvarx-doubles-as-it-sells-immuno-oncology-assets-to-portage-for-us76mln-202841.html SalvaRx patently making progress https://www.tech-capital.com/companies/news/129554/salvarx-patently-making-progress-129554.html Mon, 22 Aug 2016 09:36:00 +0100 https://www.tech-capital.com/companies/news/129554/salvarx-patently-making-progress-129554.html SalvaRx boss hails 'transformative' 2015 https://www.tech-capital.com/companies/news/127528/salvarx-boss-hails-transformative-2015-127528.html Mon, 27 Jun 2016 07:16:00 +0100 https://www.tech-capital.com/companies/news/127528/salvarx-boss-hails-transformative-2015-127528.html SalvaRx’s immunotherapy pipeline presents rare opportunity for AIM investors https://www.tech-capital.com/companies/news/125503/salvarxs-immunotherapy-pipeline-presents-rare-opportunity-for-aim-investors-125503.html Tue, 03 May 2016 14:16:00 +0100 https://www.tech-capital.com/companies/news/125503/salvarxs-immunotherapy-pipeline-presents-rare-opportunity-for-aim-investors-125503.html Human trials just around the corner, says SalvaRx boss https://www.tech-capital.com/companies/news/304973/human-trials-just-around-the-corner-says-salvarx-boss-4973.html Tue, 03 May 2016 12:25:00 +0100 https://www.tech-capital.com/companies/news/304973/human-trials-just-around-the-corner-says-salvarx-boss-4973.html SalvaRx wins €8.3mln EU grant to develop cancer drugs https://www.tech-capital.com/companies/news/125080/salvarx-wins-83mln-eu-grant-to-develop-cancer-drugs-125080.html Thu, 21 Apr 2016 10:35:00 +0100 https://www.tech-capital.com/companies/news/125080/salvarx-wins-83mln-eu-grant-to-develop-cancer-drugs-125080.html